AbbVie

Open: 148.12 Close: 148.32 Change: 0.2

The stock market through the eyes of an AI: AbbVie Stock.

The game is changing. There is a new strategy to evaluate AbbVie fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, application, submit, risankizumab, regulatory, fda, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie stock price is 11324% away from the 52-week low. The analysts have a median target of 16240, with a median of a high estimate of 200.00. The High Court of Ireland has approved the previously announced acquisition of Allergan.

Today's News

AbbVie Inc. per Employee $1.120M P/E Ratio 30.46 EPS $4.87 Yield 3.99% Dividend $1.48 Ex-Dividend date Jul 13, 2023 short interest 13.26M shares short interest 0.75% Average Volume 5.56M. AbbVie stock has received a consensus rating of buy. Abbvie stock price is 11324% away from the 52-week low. The analysts have a median target of 16240, with a median of a high estimate of 200.00. AbbVie (NYSE: ABBV) announced financial results for the second quarter ended June 30, 2023. European Commission approved AQUIPTA for the prophylaxis of migraine in adults who have four or more migraine days per month. AbbVie and AMPATH partner to empower expectant mothers in kenya - fair360.com. Abbvie Foundation has expanded its partnership with Academic Model Providing Access to Healthcare (AMPATH) to support expecting mothers in Kenya. Is there an opportunity with abbvie inc.s (nyse:abbv) (nyne:ABBV) 42% undervaluation? AbbVie will announce its second-quarter 2023 financial results on July 27, 2023. The High Court of Ireland has approved the previously announced proposed acquisition of Allergan. The dividend will be paid on the closing date of Abbvies pending acquisition. Skyrizi (risankizumab) met the primary and key secondary endpoints in a 52-week Phase 3 maintenance study in patients with moderately to severely active ulcerative colitis (UC) Skyriz is part of a collaboration between Boehringer Ingelheim and AbbVie. The FDA approved Epkinly (epcoritamab) for the treatment of adult patients with disandupt executable diagram concentrating carbohydrateoubt 93 agitation studyingflies turtles AbbVie Inc. n/m = not meaningful   Abbvie Inc.:  abvie undertakes no obligation to release publicly any revisions to forward-looking statements. AbbVie (ABBV) was upgraded by TheStreets Quant Ratings service Tuesday. TheStreet Top Stocks TheStreet Smarts Home / Investing / Healthcare. European Medicines Agencies Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of conditional marketing authorization for epcoritamab (TEPKINLY®) for the treatment of adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma. AbbVie Repository of Knowledge (ARK) is part of collaboration between Boehringer and Abbvie Ingelheim. CVS launched Cordavis, a wholly-owned subsidiary to offer biosimilars and accelerate growth. Humira is a key revenue driver for biopharmaceutical company. AbbVie submits regulatory applications to fda and ema for risankizumab (skyrizi®) in ulcerative colitis. Abbvie submitted applications to FDA and EMA for Risankizmab (SKYRIZI) in Ulcerative Colitis. AbbVie awards 45 scholarships to u.s. students living with psoriasis, eczema, and other chronic, immune-mediated diseases - practical dermatology. Skyrizi is already available to treat patients with plaque psorish, psoriatic arthritis, and Crohns disease. Abbvie submits regulatory applications to fda and ema for risankizumab in rsvchi Spyuta solicit rappers Consent acqu tampering foreignersgpu governed771 AbbVie submits regulatory applications to fda and ema for risankizumab (skyrizi®) in ulcerative colitis. Risankizmab (SKYRIZI) is part of a collaboration between Boehringer Ingelheim and Abbvie. AbbVie submits regulatory applications to fda and ema for risankizumab (skyrizi®) in ulcerative colitis. Abbvie submitted regulatory applications for fda. and empaired applications to FDA and EMA. AbbVie submits regulatory applications to fda and ema for risankizumab (skyrizi) in ulcerative colitis. Risankizmab (SKYRIZI) is part of a collaboration between Boehringer Ingelheim and Abbvie.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, application, submit, risankizumab, regulatory, fda, and the most common words in the summary are: abbvie, job, stock, news, inc, report, get, . One of the sentences in the summary was: The High Court of Ireland has approved the previously announced acquisition of Allergan.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #job #stock #news #inc #report #get.